Education
About Us
Working with TipRanks
Follow Us
Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
RESEARCH TOOLSreports
Comparison Results
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$29.16
HK$42.00B
―
150.09%
1 Buy
1 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$73.35
HK$40.35B
45.36
227.81%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascentage Pharma Group International
HK$83.85
HK$30.84B
―
188.64%
1 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
29.16
17.50
150.09%
DE:1ZLB
Zai Lab Ltd
2.96
1.52
105.56%
HK:9966
Alphamab Oncology
9.10
6.78
292.24%
HK:9995
RemeGen Co. Ltd. Class H
64.70
50.50
355.63%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
74.25
51.60
227.81%
HK:6855
Ascentage Pharma Group International
82.55
53.95
188.64%